v3.26.3
Consolidated Balance Sheets - USD ($)
Jul. 31, 2026
Jul. 31, 2025
Current assets    
Cash and cash equivalents $ 569,000 $ 334,000
Accounts receivable 334,000 474,000
Inventories, net 193,000 141,000
Restricted cash 75,000 75,000
Prepaid expenses 14,000 23,000
Total current assets 1,185,000 1,047,000
Property, and equipment, net 8,000 11,000
Total assets 1,193,000 1,058,000
Current liabilities    
Accounts payable 820,000 784,000
Convertible notes payable to related parties, current (including $1,015,000 and $0, respectively, past due) 3,381,000 1,175,000
Accrued liabilities 170,000 154,000
Total current liabilities 4,371,000 2,113,000
Convertible notes payable to related parties non-current 3,221,000 4,061,000
Total liabilities 7,592,000 6,174,000
Commitments and contingencies
Stockholders’ deficiency    
Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.01 par value: 250,000,000 and 200,000,000 shares authorized at July 31, 2026 and July 31, 2025, respectively, 130,017,569 shares issued and outstanding at July 31, 2026, and 111,886,473 shares issued and outstanding at July 31, 2025 1,301,000 1,119,000
Additional paid-in capital 133,777,000 132,759,000
Accumulated deficit (141,477,000) (138,994,000)
Total stockholders’ deficiency (6,399,000) (5,116,000)
Total liabilities and stockholders’ deficiency $ 1,193,000 $ 1,058,000